Pacific Biosciences Of California | PACB - Interest Expense On Debt


Pacific Biosciences Of California reported $1.74M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 25M 0 Mar/2026
Bruker USD 17.8M 9.7M Jun/2026
Danaher USD 107M 44M Jun/2026
General Electric Aerospace USD 496M 271M Dec/2025
Illumina USD 24M 2M Mar/2026
Myriad Genetics USD 4.4M 600K Dec/2025
Pacific Biosciences Of California USD 1.74M 1000 Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Revvity USD 22.99M 1.73M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
Standard Biotools USD 5K 5K Dec/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Waters USD 55M 13M Jun/2026